GlaxoSmithKline Plc released results from a trial Saturday on a vaccine to prevent infection of the human papillomavirus in girls age 10 to 14.

The data suggests that the Cervarix vaccine provides the strongest and most-prolonged protection if its given to girls at young ages, before they even encounter sexually transmitted diseases, reports Reuters. The girls given the vaccine had immune responses twice as strong as women 15-25 years of age given Cervarix

The G7 summit meeting in London kicked off a project to subsidize production of a host of new vaccines to fight illnesses and viruses worldwide.

The target areas include some of the world's poorest regions

Biological health care product provider CSL Ltd announces that a new vaccine developed by US pharmaceutical company Merck, based on CSL technology, has prevented high grade cervical pre-cancers and non-invasive cervical cancers, reports Asia Pulse.

CSL says that the Gardasil prevents the pre-cancers and non-invasive cervical cancers related to the human papillomavirus (HPV) types 16 and 18 that make up about 70 per cent of all cervical cancers

Penn State researchers discover a common virus with the potential to become a powerful cancer fighter.

Laboratory tests showed that the virus, known as adeno-associated virus type 2 (AAV2), kills many types of cancer cells without harming healthy cells

Microsoft Corp. founder Bill Gates is putting his financial muscle behind a campaign to get life-saving cervical cancer vaccines to women in poor countries.

Two rival vaccines targeting the human papillomavirus (HPV), which causes the disease, are expected to be launched in the next year or two by Merck & Co. and GlaxoSmithKline Plc